Ado-trastuzumab emtansine is used to treat patients with the following:
- Patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has spread to other parts of the body who previously received trastuzumab and a taxane, separately or in combination.
- Patients with (HER2)-positive early breast cancer who have cancer remaining in the tissue removed during surgery. These patients received treatment including trastuzumab and a taxane prior to surgery.
Ado-trastuzumab emtansine may also be used for other treatments.
Our Medication Sheet
This sheet is available to download as an Adobe PDF.Get Ado-Trastuzumab Emtansine Medication Sheet